178 related articles for article (PubMed ID: 7551293)
1. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues.
Misra DN; Dickman PS; Yunis EJ
Diagn Mol Pathol; 1995 Jun; 4(2):128-35. PubMed ID: 7551293
[TBL] [Abstract][Full Text] [Related]
2. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas.
Hachitanda Y; Saito M; Mori T; Hamazaki M
Med Pediatr Oncol; 1997 Aug; 29(2):135-8. PubMed ID: 9180916
[TBL] [Abstract][Full Text] [Related]
3. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections.
Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J
Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897
[TBL] [Abstract][Full Text] [Related]
4. Assessment of NMYC amplification: a comparison of FISH, quantitative PCR monoplexing and traditional blotting methods used with formalin-fixed, paraffin-embedded neuroblastomas.
Layfield LJ; Willmore-Payne C; Shimada H; Holden JA
Anal Quant Cytol Histol; 2005 Feb; 27(1):5-14. PubMed ID: 15794447
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples.
Somasundaram DB; Aravindan S; Yu Z; Jayaraman M; Tran NTB; Li S; Herman TS; Aravindan N
BMC Cancer; 2019 Jan; 19(1):106. PubMed ID: 30691436
[TBL] [Abstract][Full Text] [Related]
7. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
Bhargava R; Oppenheimer O; Gerald W; Jhanwar SC; Chen B
Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.
Tanaka S; Tajiri T; Noguchi S; Shono K; Ihara K; Hara T; Suita S
J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373
[TBL] [Abstract][Full Text] [Related]
9. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Mathew P; Valentine MB; Bowman LC; Rowe ST; Nash MB; Valentine VA; Cohn SL; Castleberry RP; Brodeur GM; Look AT
Neoplasia; 2001; 3(2):105-9. PubMed ID: 11420745
[TBL] [Abstract][Full Text] [Related]
10. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
11. Use of chromogenic in situ hybridization to identify MYCN gene copy number in neuroblastoma using routine tissue sections.
Thorner PS; Ho M; Chilton-MacNeill S; Zielenska M
Am J Surg Pathol; 2006 May; 30(5):635-42. PubMed ID: 16699319
[TBL] [Abstract][Full Text] [Related]
12. MYCN gene amplification. Identification of cell populations containing double minutes and homogeneously staining regions in neuroblastoma tumors.
Yoshimoto M; Caminada De Toledo SR; Monteiro Caran EM; de Seixas MT; de Martino Lee ML; de Campos Vieira Abib S; Vianna SM; Schettini ST; Anderson Duffles Andrade J
Am J Pathol; 1999 Nov; 155(5):1439-43. PubMed ID: 10550298
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
Schwab M
Brain Pathol; 1990 Sep; 1(1):41-6. PubMed ID: 1669692
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J
Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827
[TBL] [Abstract][Full Text] [Related]
15. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R
Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200
[TBL] [Abstract][Full Text] [Related]
16. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.
Tsai HY; Hsi BL; Hung IJ; Yang CP; Lin JN; Chen JC; Tsai SF; Huang SF
Hum Pathol; 2004 Nov; 35(11):1397-403. PubMed ID: 15668898
[TBL] [Abstract][Full Text] [Related]
17. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
Pandita A; Godbout R; Zielenska M; Thorner P; Bayani J; Squire JA
Genes Chromosomes Cancer; 1997 Nov; 20(3):243-52. PubMed ID: 9365831
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line.
Corvi R; Savelyeva L; Amler L; Handgretinger R; Schwab M
Eur J Cancer; 1995; 31A(4):520-3. PubMed ID: 7576957
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y
Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and molecular cytogenetics in neuroblastoma.
Avet-Loiseau H; Venuat AM; Benard J; Leibovitch MP; Hartmann O; Bernheim A
Cancer; 1995 Apr; 75(7):1694-9. PubMed ID: 8826929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]